John Lai: Well, thanks for the question David. So the expansion, actually, if you look at it, has multiple clean room and potential for what we call current manufacturing practice, current good manufacturing practice certifications. It has the ability to scale at much higher volumes with the addition of automated equipment. Also, that clearly identifies future potential product pipelines to run through there. Because, if you’re just using our current facility, you would have to shut down the manufacturing of Spryng for the next product pipeline and then rotate back forth. So there’s tremendous efficiencies and scalability in this new facility. And you would see that it’s probably 3.5 times the size of what we currently have from a production standpoint. So that’s one way to answer it. So we’re just really positioning for future growth, potential future rapid growth.
Unidentified Analyst: Excellent, so what particular products would you have in mind then to be simultaneously scaling in a facility that can serve both of those end results?
John Lai: So we’re not moving into the other facility until probably August. And as you see on our studies, everything is in equine, canine and feline. So we’ll have those products out. The next year, we could have a couple of other products that we’re ready – they’re ready to roll out any time, we just have to have studies to support it. So we need to prep for that and have that place ready.
Unidentified Analyst: Terrific, so it gives you some dual path leveragability in your facility is kind of the net-net of that?
John Lai: Yes absolutely. And also a disaster recovery type potential situation. So we won’t get disrupted in the Spryng aspect, no matter what. Well, I shouldn’t say, you could have a major disaster where a lot of stuff gets taken out. But otherwise, we’re doing the right thing to make sure we don’t interrupt Spryng with the momentum we have going right now. Because we’re seeing a lot of veterinary doctors now actually putting up videos of success stories of dogs and horses, some veterinary doctors are actually started to inject some cats and seen really good results. I mean those videos are very powerful when they’re coming from the vets themselves to let the public and other veterinary doctors know how well the product is working.
Unidentified Analyst: That’s it, thanks for the overview.
John Lai: Thank you.
Operator: We are now allowing the number ending in 9170.
John Lai: Go ahead.
Unidentified Analyst: My name is just wanted to call in real quick, less of a question, first off, congratulations on the great quarter?
John Lai: Thank you.
Unidentified Analyst: So I started using those, product back in October on a family friend race horse, this horse in the past, very expensive horse, so it’s a very, very well that ended up with a bad ankle. His ankle became the size of a softball. He just couldn’t really run any more. So one injection, and he performed incredibly just a week later and then ended up winning quite a few races within the last past four months or five months. So we are five months out from injection now, and we were thinking that it would be time for another one, start wearing off. The results are just getting better. We feel that maybe that protein matrix has started to rebuild the joints. Very surprised I really thought we’d be ready for another injection. So but my father, as some of you know, is a very high-level veterinarian in the racing world, and he’s just so impressed. He said he’s never seen anything like this before.
John Lai: So yes, I remember the early onset, he didn’t believe this stuff would work.
Unidentified Analyst: No we did it. It’s such an incredible step-up from what we were using before. Cortisone, over time, as most of you know, degrades the joint which from what we understand about this is just not going to be the case, which is huge for longevity. You buy a $300,000 horse, you want it to last.